BCM
FLACU

Bluefin Capital Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Bluefin Capital Management’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-67,643
Closed -$682K – 963
2021
Q2 		$682K Sell
67,643
-746
-1% -$7.56K 0.04% 233
2021
Q1 		$698K Sell
68,389
-1,611
-2% -$17.2K 0.03% 248
2020
Q4 		$729K Buy
+70,000
New +$731K 0.04% 230

Other funds holding FLACU

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Bluefin Capital Management's FLACU Position: Q3 2021 in Review

Bluefin Capital Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q3 2021, closing a stake of 67,643 shares — an estimated $682K sold.

Bluefin Capital Management first reported a position in FLACU in Q4 2020 and held it in 3 quarters. The position peaked at $729K in Q4 2020. 26 funds tracked by Wall St. Rank hold FLACU as of Q3 2021.

  • Bluefin Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • Bluefin Capital Management sold 67,643 Frazier Lifesciences Acquisition Corporation Unit shares in Q3 2021, an estimated $682K.
  • Bluefin Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
  • Bluefin Capital Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $729K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q3 2021.

Based on Bluefin Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.